» Articles » PMID: 29933397

Human TSCM Cell Dynamics in Vivo Are Compatible with Long-lived Immunological Memory and Stemness

Abstract

Adaptive immunity relies on the generation and maintenance of memory T cells to provide protection against repeated antigen exposure. It has been hypothesised that a self-renewing population of T cells, named stem cell-like memory T (TSCM) cells, are responsible for maintaining memory. However, it is not clear if the dynamics of TSCM cells in vivo are compatible with this hypothesis. To address this issue, we investigated the dynamics of TSCM cells under physiological conditions in humans in vivo using a multidisciplinary approach that combines mathematical modelling, stable isotope labelling, telomere length analysis, and cross-sectional data from vaccine recipients. We show that, unexpectedly, the average longevity of a TSCM clone is very short (half-life < 1 year, degree of self-renewal = 430 days): far too short to constitute a stem cell population. However, we also find that the TSCM population is comprised of at least 2 kinetically distinct subpopulations that turn over at different rates. Whilst one subpopulation is rapidly replaced (half-life = 5 months) and explains the rapid average turnover of the bulk TSCM population, the half-life of the other TSCM subpopulation is approximately 9 years, consistent with the longevity of the recall response. We also show that this latter population exhibited a high degree of self-renewal, with a cell residing without dying or differentiating for 15% of our lifetime. Finally, although small, the population was not subject to excessive stochasticity. We conclude that the majority of TSCM cells are not stem cell-like but that there is a subpopulation of TSCM cells whose dynamics are compatible with their putative role in the maintenance of T cell memory.

Citing Articles

A variational deep-learning approach to modeling memory T cell dynamics.

van Dorp C, Gray J, Paik D, Farber D, Yates A bioRxiv. 2025; .

PMID: 40060443 PMC: 11888226. DOI: 10.1101/2024.07.08.602409.


Alginate-based artificial antigen presenting cells expand functional CD8 T cells with memory characteristics for adoptive cell therapy.

Omotoso M, Est-Witte S, Shannon S, Li S, Nair N, Neshat S Biomaterials. 2024; 313:122773.

PMID: 39217794 PMC: 11423771. DOI: 10.1016/j.biomaterials.2024.122773.


The dynamics and longevity of circulating CD4+ memory T cells depend on cell age and not the chronological age of the host.

Bullock M, Hogan T, Williams C, Morris S, Nowicka M, Sharjeel M PLoS Biol. 2024; 22(8):e3002380.

PMID: 39137219 PMC: 11321570. DOI: 10.1371/journal.pbio.3002380.


The dynamics and longevity of circulating CD4 memory T cells depend on cell age and not the chronological age of the host.

Bullock M, Hogan T, Williams C, Morris S, Nowicka M, Sharjeel M bioRxiv. 2024; .

PMID: 38948729 PMC: 11212895. DOI: 10.1101/2023.10.16.562650.


A guide to adaptive immune memory.

Lam N, Lee Y, Farber D Nat Rev Immunol. 2024; 24(11):810-829.

PMID: 38831162 DOI: 10.1038/s41577-024-01040-6.


References
1.
Di Rosa F . Maintenance of memory T cells in the bone marrow: survival or homeostatic proliferation?. Nat Rev Immunol. 2016; 16(4):271. DOI: 10.1038/nri.2016.31. View

2.
Grinenko T, Arndt K, Portz M, Mende N, Gunther M, Cosgun K . Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells. J Exp Med. 2014; 211(2):209-15. PMC: 3920556. DOI: 10.1084/jem.20131115. View

3.
Gerlach C, Rohr J, Perie L, van Rooij N, van Heijst J, Velds A . Heterogeneous differentiation patterns of individual CD8+ T cells. Science. 2013; 340(6132):635-9. DOI: 10.1126/science.1235487. View

4.
Buchholz V, Flossdorf M, Hensel I, Kretschmer L, Weissbrich B, Graf P . Disparate individual fates compose robust CD8+ T cell immunity. Science. 2013; 340(6132):630-5. DOI: 10.1126/science.1235454. View

5.
Hofer T, Busch K, Klapproth K, Rodewald H . Fate Mapping and Quantitation of Hematopoiesis In Vivo. Annu Rev Immunol. 2016; 34:449-78. DOI: 10.1146/annurev-immunol-032414-112019. View